R.PR
REGISTERED-PRINCIPAL REGISTER
11/16/2021
Back to search
Official data from USPTO
AMONDYS 45 (CASIMERSEN)
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/16/2021
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
01/11/2021
Registration date
11/16/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/16/2021
Last transaction
11/16/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/25/2021
First use in commerce
02/25/2021
Drawing code
3
Owner type
03
Owner location
Cambridge, MA
Examiner
CLARKE, NANCY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a hexagon, bisected by a swoosh, followed by the text and numeral "AMONDYS 45" over the text "(casimersen)".
Holders and representatives
Holders
Sarepta Therapeutics, Inc.
Representatives
Maury M. Tepper, III TEPPER & EYSTER, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations featuring antisense oligonucleotidesfor the treatment of neuromuscular diseases and disorders
Publications
History of USPTO decisions and trademark events.
26 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/13/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/12/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/12/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/12/2021
IUAF
USE AMENDMENT FILED
09/27/2021
EISU
TEAS STATEMENT OF USE RECEIVED
09/27/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/21/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/27/2021
PUBO
PUBLISHED FOR OPPOSITION
07/27/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
06/24/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/24/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
06/24/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/22/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2021
GNRT
NON-FINAL ACTION E-MAILED
06/02/2021
CNRT
NON-FINAL ACTION WRITTEN
06/02/2021
DOCK
ASSIGNED TO EXAMINER
05/29/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2021
NWAP
NEW APPLICATION ENTERED
01/14/2021
Continuous trademark protection
Get notified about every new filing that threatens AMONDYS 45 (CASIMERSEN) or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.